Feb. 14,Toronto, Ont. – Theralase Technologies Inc. has announced the appointment ofDr. Arkady Mandel as Chief Scientific Officer.
Feb. 14,Toronto, Ont. – Theralase Technologies Inc. has announced the appointment ofDr. Arkady Mandel as Chief Scientific Officer.
ArkadyMandel, M.D., Ph.D., DSc., earned his designation as a medical doctor from theMoscow State Medical University in 1978. His medical residency includedinternships in dermatology, infectious diseases, urology and venereal diseasesat the Central Research Institute of Dermatology and Venerology in 1980,followed by a Ph.D. from the same institution in 1982.
Inrecognition of his scientific knowledge, original research, publications andextensive contributions to the field of clinical medicine, Dr. Mandel was thenawarded the highest academic research degree in science, that of a Doctor ofScience. Dr. Mandel's Doctor of Science accreditation majored in biochemistry,microbiology, immunology, biophysics, and photobiology, and was awarded jointlyfrom the Academy of Sciences and the U.S.S.R. Ministry of Public Health in1989.
Dr.Mandel is one of the key founders of the therapeutic use of lasers indermatology and other areas of clinical medicine, as well as the originator anddeveloper of phototherapy methods that offer numerous benefits to patientsthroughout the world.
RogerDumoulin-White, President and CEO of Theralase Inc. stated that, "We are extremely fortunate to attract an accredited researcher of such a high calibre as Arkady. With over 100 original papers and scientific monographs to his name,combined with over 200 international patents attributed to his research, Dr.Mandel is not only an esteemed medical professional and an internationally respected scientist, but also an experienced executive manager of research and development teams dedicated to the field of biotechnology and drug development.
We look forward to working with Arkady to lead the research and development ofour core technologies through to commercialization; specifically, our patentedphoto dynamic technology platform for the treatment of cancer and eradicationof bacteria and viruses, as well as our patented super-pulsed biofeedback lasertechnology used for the treatment of inflammation and pain in numerous medicalconditions."
For more information visit the corporate or regulatory website at www.theralase.com
Print this page
